Purchase Order HHSF223201510813P

This firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to We Pharma, Inc., doing business as WEP Clinical. The contract, valued at $197,000.00, is for the procurement of pharmaceutical drug products to support the FDA's Center for Drug Evaluation and Research (CDER) research and regulatory activities. WEP Clinical, a self-certified small disadvantaged business, specializes in supplying currently marketed drug products for FDA research studies, regulatory science programs, and emergency response needs. The contract does not have a set-aside designation. WEP Clinical holds two significant Indefinite Delivery Contracts with the FDA, valued at $9.5 million and $6 million respectively, which have resulted in multiple task orders for various FDA offices across the country to support the agency's mission of ensuring drug safety, effectiveness, and quality.